newsfilter
← Latest News
GlobeNewswire·

Myriad Genetics Adds F8, FXN Genes to Foresight Universal Plus Panel

SALT LAKE CITY, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ:MYGN), a leader in molecular diagnostic testing and precision medicine, today announced it has added two genes, F8 and FXN, to the